Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMV390048 in Acute Uncomplicated Malaria
NCT02880241Phase 2Terminated
- Sponsor
- Medicines for Malaria Venture
- Start
- Oct 2017
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
A Phase 2 trial of MMV390048 in malaria, Plasmodium falciparum malaria, sponsored by Medicines for Malaria Venture. Started Oct 2017; status: terminated.
02
Drugs
MMV390048
03
Conditions
malariaPlasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02880241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02880241.